Status:
COMPLETED
Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Pneumonia
Abdominal Infection
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will measure the pharmacokinetics of doripenem in skeletal muscle, subcutaneous adipose tissue, bronchoalveolar lavage and plasma of intubated intensive care patients.
Detailed Description
Methods: microdialysis, blood sampling, bronchoalveolar lavage
Eligibility Criteria
Inclusion
- endotracheal intubation; pneumonia or complicated abdominal infection or complicated urinary tract infection
Exclusion
- allergy to doripenem, hemodialysis
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01414959
Start Date
August 1 2011
End Date
July 1 2013
Last Update
August 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Med. Univ. of Vienna
Vienna, Austria, 1090